Evidence for persistent Chlamydia pneumoniae infection of human coronary atheromas

Nicole Borel1, James T Summersgill, Sanghamitra Mukhopadhyay

  • 1Institute of Veterinary Pathology, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 268, CH-8057 Zurich, Switzerland. n.borel@access.unizh.ch

Atherosclerosis
|November 22, 2007
PubMed

Insights

Researchers visualized persistent Chlamydia pneumoniae bacteria in human atherosclerotic tissues. This study reveals aberrant bacterial bodies in coronary artery disease, offering new insights into atherosclerosis pathogenesis.

Area of Science:

  • Microbiology
  • Pathology
  • Cardiovascular Research

Background:

  • Chlamydia pneumoniae is an intracellular bacterium implicated in atherosclerosis.
  • Persistent forms and specific developmental stages of C. pneumoniae in human atherosclerotic tissues remain poorly characterized.
  • Understanding bacterial presence is crucial for elucidating disease mechanisms.

Purpose of the Study:

  • To identify and characterize developmental stages of Chlamydia pneumoniae, particularly persistent forms, within human atherosclerotic tissues.
  • To investigate the presence of aberrant bacterial bodies in vivo using advanced microscopy techniques.
  • To confirm the chlamydial origin of observed structures.

Main Methods:

  • Utilized transmission electron microscopy (TEM) combined with immunogold labeling.
  • Employed antibodies specific for chlamydial heat shock proteins (GroEL, GroES) and chlamydial lipopolysaccharide (LPS)/MOMP.
  • Examined archival coronary atheromatous heart tissues from patients.

Main Results:

  • Identified intracellular, atypical, round to oval structures resembling chlamydial reticulate bodies within smooth muscle cells, macrophages, and fibroblasts.
  • Demonstrated these structures were of chlamydial origin using double immunogold labeling.
  • Confirmed the presence of aberrant bodies of C. pneumoniae in vivo in atherosclerotic tissues.

Conclusions:

  • The study provides the first description of C. pneumoniae developmental stages in human atherosclerotic tissues.
  • Aberrant bodies of C. pneumoniae are present in vivo within coronary atheromatous tissues.
  • These findings contribute to understanding the role of C. pneumoniae in the pathogenesis of atherosclerosis.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...